JANX·Nasdaq·US
Janux Therapeutics
Janux Therapeutics is a clinical-stage biopharmaceutical company focused on developing tumor-activated immunotherapies for cancer. Its platform includes TRACTr, TRACIr, and ARM technologies used to advance bispecific T cell engager programs and related oncology candidates.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.